{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:44:25Z","timestamp":1789901065070,"version":"4.0.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"49-50","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.vaccine.2006.06.049","type":"journal-article","created":{"date-parts":[[2006,7,7]],"date-time":"2006-07-07T10:21:22Z","timestamp":1152267682000},"page":"7037-7045","source":"Crossref","is-referenced-by-count":66,"title":["Mumps vaccine virus strains and aseptic meningitis"],"prefix":"10.1016","volume":"24","author":[{"given":"Marie-Claude","family":"Bonnet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley A.","family":"Plotkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.06.049_bib1","unstructured":"World Health Organization. Mumps Vaccine. In: Core Information for the Development of Immunization Policy: 2002 Update. Geneva, Switzerland: World Health Organization; 2002:76\u201386. http:\/\/www.who.int\/vaccines-documents\/DocsPDF02\/www557.pdf, accessed December 20, 2005."},{"key":"10.1016\/j.vaccine.2006.06.049_bib2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/ije\/31.5.983","article-title":"Commentary: ongoing debate over the safety of the different mumps vaccine strains impacts mumps disease control","volume":"31","author":"Fullerton","year":"2002","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2006.06.049_bib3","series-title":"Vaccines","first-page":"441","article-title":"Mumps vaccine","author":"Plotkin","year":"2004"},{"key":"10.1016\/j.vaccine.2006.06.049_bib4","unstructured":"Louisiana Department of Health & Hospitals. Viral (aseptic meningitis). Available at: http:\/\/www.oph.dhh.louisiana.gov\/infectiousdisease\/docs\/disease_updates_04\/MeningitisViralManual.pdf, accessed December 20, 2005."},{"key":"10.1016\/j.vaccine.2006.06.049_bib5","first-page":"345","article-title":"Mumps virus vaccines","volume":"76","author":"World Health Organization","year":"2001","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2006.06.049_bib6","unstructured":"World Health Organization. The mumps vaccine. Available at: http:\/\/www.who.int\/vaccines-diseases\/diseases\/mumps vaccine.shtml, accessed December 10, 2004."},{"key":"10.1016\/j.vaccine.2006.06.049_bib7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1542\/pir.17-4-120","article-title":"Almost extinct diseases: measles, mumps, rubella, and pertussis","volume":"17","author":"Gold","year":"1996","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.vaccine.2006.06.049_bib8","first-page":"91","article-title":"Observation on a mumps epidemic in a virgin population","volume":"69","author":"Philip","year":"1959","journal-title":"Am J Hyg"},{"key":"10.1016\/j.vaccine.2006.06.049_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/jama.199.13.113","article-title":"A mumps epidemic on St. George Island Alaska","volume":"199","author":"Reed","year":"1967","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2006.06.049_bib10","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0140-6736(89)92004-7","article-title":"Mumps vaccine complications: which strain?","author":"Nalin","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.06.049_bib11","first-page":"302","article-title":"Aseptic meningitis after vaccination against measles and mumps","volume":"8","author":"Cizman","year":"1989","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2006.06.049_bib12","doi-asserted-by":"crossref","unstructured":"Wharton M, Chorba TL, Vogt RL, Morse DL. Case definitions for public health surveillance. MMWR. 1990; 39(RR-13):1\u201343. Available at: http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/00025629.htm, accessed December 20, 2005.","DOI":"10.1037\/e546082006-001"},{"key":"10.1016\/j.vaccine.2006.06.049_bib13","unstructured":"Brighton Collaboration Definitions and Guidelines, 2004. Available at: http:\/\/brightoncollaboration.org\/internet\/en\/index\/definition_guidelines.html, accessed December 20, 2005."},{"key":"10.1016\/j.vaccine.2006.06.049_bib14","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/0264-410X(91)90223-S","article-title":"Nucleotide sequence analysis of Urabe mumps vaccine strain that caused meningitis in vaccine recipients","volume":"9","author":"Brown","year":"1991","journal-title":"Vaccine"},{"issue":"RR\u20138","key":"10.1016\/j.vaccine.2006.06.049_bib15","first-page":"1","article-title":"Measles, mumps, and rubella\u2014vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"48","author":"Centers for Disease Control Prevention","year":"1998","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2006.06.049_bib16","unstructured":"World Health Organization Global Advisory Committee on Vaccine Safety. Adverse events following mumps vaccination. Available at: http:\/\/www.who.int\/vaccine_safety\/topics\/mumps\/statement\/en\/, accessed December 20, 2005."},{"key":"10.1016\/j.vaccine.2006.06.049_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF01955892","article-title":"Withdrawal of a mumps vaccine: reasons and impacts","volume":"152","author":"Schmitt","year":"1993","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2006.06.049_bib18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0140-6736(95)92311-X","article-title":"Aseptic meningitis caused by measles mumps rubella vaccine in Japan","volume":"346","author":"Ueda","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.06.049_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/(SICI)1099-1654(199807\/09)8:3<129::AID-RMV213>3.0.CO;2-Z","article-title":"Genetic studies on a mumps vaccine strain associated with meningitis","volume":"8","author":"Brown","year":"1998","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2006.06.049_bib20","first-page":"388","article-title":"Mumps Prevention Recommendations of the Immunization Practices Advisory Committee (ACIP)","volume":"38","author":"Centers for Disease Control Prevention","year":"1989","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2006.06.049_bib21","first-page":"253","article-title":"Vaccine-related mumps meningitis\u2014Canada","volume":"16","author":"Furesz","year":"1990","journal-title":"Can Dis Wkly Rep"},{"key":"10.1016\/j.vaccine.2006.06.049_bib22","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/0140-6736(92)92322-7","article-title":"Mumps meningitis and measles, mumps, and rubella vaccine","volume":"340","author":"Colville","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.06.049_bib23","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0140-6736(93)91069-X","article-title":"Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children","volume":"341","author":"Miller","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.06.049_bib24","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0140-6736(95)90471-9","article-title":"A new method for active surveillance of adverse events from diphtheria\/tetanus\/pertussis and measles\/mumps\/rubella vaccines","volume":"345","author":"Farrington","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.06.049_bib25","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/ije\/24.6.1223","article-title":"Estimation of the risk of aseptic meningitis associated with mumps vaccination, France 1991\u20131993","volume":"24","author":"Rebiere","year":"1995","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2006.06.049_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/(SICI)1099-1557(199601)5:1<33::AID-PDS210>3.0.CO;2-7","article-title":"Aseptic meningitis following mumps vaccine. A retrospective survey by the French regional pharmacovigilance centres and by Pasteur-Merieux Serums & Vaccins","volume":"5","author":"Jonville-Bera","year":"1996","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2006.06.049_bib27","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/tropej\/48.6.354","article-title":"Safety evaluation of MMR vaccine during a primary school campaign in Saudi Arabia","volume":"48","author":"Al-Mazrou","year":"2002","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.vaccine.2006.06.049_bib28","first-page":"240","article-title":"An evaluation of the adverse reaction potential of three measles-mumps\u2013rubella combination vaccines","volume":"12","author":"Dos Santos","year":"2002","journal-title":"Rev Salud Publica\/Pan Am J Public Health"},{"key":"10.1016\/j.vaccine.2006.06.049_bib29","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00006454-199103000-00007","article-title":"A prefecture-wide survey of mumps meningitis associated with measles, mumps and rubella vaccine","volume":"10","author":"Fujinaga","year":"1991","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2006.06.049_bib30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00006454-199103000-00008","article-title":"Aseptic meningitis as a complication of mumps vaccination","volume":"10","author":"Sugiura","year":"1991","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2006.06.049_bib31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1442-200X.1996.tb03471.x","article-title":"Adverse events associated with MMR vaccines in Japan","volume":"38","author":"Kimura","year":"1996","journal-title":"Acta Paediatr Japonica"},{"key":"10.1016\/j.vaccine.2006.06.049_bib32","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/aje\/kwf167","article-title":"Risk analysis of aseptic meningitis after measles-mumps-rubella vaccination in Korean children by using a case-crossover design","volume":"157","author":"Ki","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2006.06.049_bib33","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/oxfordjournals.aje.a010239","article-title":"Outbreak of aseptic meningitis associated with mass vaccination with a Urabe-containing measles\u2013mumps\u2013rubella vaccine: implications for immunization programs","volume":"151","author":"Dourado","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2006.06.049_bib34","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00006454-199705000-00009","article-title":"Risk of hospitalization because of aseptic meningitis after measles\u2013mumps\u2013rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety Datalink (VSD) Project","volume":"16","author":"Black","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2006.06.049_bib35","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1542\/peds.100.5.767","article-title":"MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project","volume":"100","author":"Davis","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2006.06.049_bib36","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/00006454-200012000-00002","article-title":"Serious adverse events after measles\u2013mumps\u2013rubella vaccination during a fourteen-year prospective follow-up","volume":"19","author":"Patja","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2006.06.049_bib37","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1542\/peds.110.5.957","article-title":"Neurologic disorders after measles\u2013mumps\u2013rubella vaccination","volume":"110","author":"Makela","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2006.06.049_bib38","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/0264-410X(90)90245-H","article-title":"Measles\u2013mumps vaccination in the FRG: an empirical analysis after 14 years of use. II. Tolerability and analysis of spontaneously reported side effects","volume":"8","author":"Fescharek","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.06.049_bib39","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s15010-002-3027-8","article-title":"Surveillance of measles-mumps-rubella vaccine-associated aseptic meningitis in Germany","volume":"30","author":"Schlipkoter","year":"2002","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2006.06.049_bib40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00006454-199901000-00011","article-title":"Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children","volume":"18","author":"Usonis","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2006.06.049_bib41","first-page":"4","article-title":"Evaluation of the Bahamas\u2019 MMR Campaign","volume":"21","author":"PAHO","year":"1999","journal-title":"EPI Newslett."},{"key":"10.1016\/j.vaccine.2006.06.049_bib42","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0264-410X(01)00438-8","article-title":"Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the L-Zagreb mumps strain","volume":"20","author":"Da Cunha","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.06.049_bib43","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/ije\/31.5.978","article-title":"The risk of aseptic meningitis associated with the L-Zagreb mumps vaccine strain following mass vaccination with measles\u2013mumps\u2013rubella vaccine, Rio Grande do Sul, Brazil, 1997","volume":"31","author":"Da Silveira","year":"2002","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2006.06.049_bib44","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1590\/S0036-46652001000500012","article-title":"Aseptic meningitis in a large MMR vaccine campaign (590,609 people) in Curitiba, Parana, Brazil, 1998","volume":"43","author":"Arruda","year":"2001","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.vaccine.2006.06.049_bib45","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1016\/j.vaccine.2005.05.029","article-title":"No definitive evidence for L-Zagreb mumps strain associated aseptic meningitis: a review with special reference to the da Cunha study","volume":"23","author":"Kulkarni","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.06.049_bib46","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1023\/A:1024698900332","article-title":"for the Swiss Sentinel Surveillance Network Comparison of the effectiveness of two mumps vaccines during an outbreak in Switzerland in 1999 and 2000: a case\u2013cohort study","volume":"18","author":"Richard","year":"2003","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.vaccine.2006.06.049_bib47","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-1157(83)80021-3","article-title":"The immunizing effect and reactogenicity of two live attenuated mumps virus vaccines in Swedish schoolchildren","volume":"11","author":"Christenson","year":"1983","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2006.06.049_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1651-2227.1983.tb09661.x","article-title":"Comparison of the Urabe Am9-Schwarz and Jeryl Lynn-Moraten combinations of mumps-measles vaccines in young children","volume":"72","author":"Vesikari","year":"1983","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.vaccine.2006.06.049_bib49","first-page":"843","article-title":"Clinical trial of a new trivalent measles\u2013mumps\u2013rubella vaccine in young children","volume":"138","author":"Vesikari","year":"1984","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.vaccine.2006.06.049_bib50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/jmv.1890180109","article-title":"A controlled trial for evaluating two live attenuated mumps\u2013measles vaccines (Urabe Am9-Schwarz and Jeryl Lynn-Moraten) in young children","volume":"18","author":"Popow-Kraupp","year":"1986","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2006.06.049_bib51","first-page":"100","article-title":"Estimation de l\u2019efficacit\u00e9 de trois souches vaccinales ourliennes au cours d\u2019une \u00e9pid\u00e9mie d\u2019oreillons dans le canton de Gen\u00e8ve","volume":"46","author":"Chamot","year":"1998","journal-title":"Rev Epidem Sant\u00e9 Publ"},{"key":"10.1016\/j.vaccine.2006.06.049_bib52","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/0140-6736(91)92601-W","article-title":"Vaccine safety versus vaccine efficacy in mass immunisation programmes","volume":"338","author":"Nokes","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.06.049_bib53","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/bmj.319.7206.352","article-title":"Comparative efficacy of three mumps vaccines during a disease outbreak in eastern Switzerland","volume":"319","author":"Schlegel","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2006.06.049_bib54","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF01324283","article-title":"Comparaison de l\u2019efficacit\u00e9 de diff\u00e9rentes souches de vaccin ourlien: une enqu\u00eate en milieu scolaire","volume":"41","author":"Toscani","year":"1996","journal-title":"Soz Pr\u00e2ventivmed"},{"key":"10.1016\/j.vaccine.2006.06.049_bib55","first-page":"3","article-title":"Mumps and mumps vaccine: a global review","volume":"77","author":"Galazka","year":"1999","journal-title":"Bull WHO"},{"key":"10.1016\/j.vaccine.2006.06.049_bib56","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0264-410X(94)00086-3","article-title":"Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines","volume":"13","author":"Miller","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.06.049_bib57","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/0264-410X(95)00098-L","article-title":"Measles, mumps and rubella antibodies in children 5\u20136 years after immunization: effect of vaccine type and age of vaccination","volume":"13","author":"Boulianne","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.06.049_bib58","unstructured":"UNICEF. Vaccine projections: quantities and pricing; 2004. Available at: http:\/\/www.unicef.org\/supply\/files\/Projections_for_2004.pdf, accessed June 22, 2005."},{"key":"10.1016\/j.vaccine.2006.06.049_bib59","unstructured":"UNICEF. Vaccine projections: quantities and pricing; 2002. Available at: http:\/\/www.unicef.org\/supply\/files\/2002_Vaccine_Projection.pdf, accessed June 22, 2005."},{"key":"10.1016\/j.vaccine.2006.06.049_bib60","unstructured":"Expanded Program on Immunization in the Americas. PAHO's Revolving Fund for vaccine prices for 2004. EPI Newsletter 2004;XXVI:7\u20138. Available at: http:\/\/www.paho.org\/english\/ad\/fch\/im\/sne2601.pdf, accessed June 22, 2005."},{"key":"10.1016\/j.vaccine.2006.06.049_bib61","first-page":"264","article-title":"Economic analyses of rubella and rubella vaccines: a global review","volume":"80","author":"Hinman","year":"2002","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.vaccine.2006.06.049_bib62","unstructured":"Centers for Disease Control and Prevention. Immunization Policy Fact Sheet. Immunization Appropriations FY; 2005. Available at: http:\/\/www.astho.org\/pubs\/FY04appropfactsheet.pdf, accessed December 20, 2005."},{"key":"10.1016\/j.vaccine.2006.06.049_bib63","first-page":"301","article-title":"Meningitis associated with measles\u2013mumps\u2013rubella vaccines","volume":"67","author":"World Health Organization","year":"1992","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2006.06.049_bib64","first-page":"387","article-title":"Meningitis associated with measles\u2013mumps\u2013rubella vaccines","volume":"67","author":"World Health Organization","year":"1992","journal-title":"Wkly Epidemiol Rec"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06007778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06007778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T18:18:23Z","timestamp":1555697903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06007778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":64,"journal-issue":{"issue":"49-50","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0264410X06007778"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.06.049","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}